Articles By Anuja Singh
Can OpenLoop’s Acquisition of Hey Revia Redefine How AI Automates Telehealth Communication for Thousands…
Key Highlights A Landmark Acquisition Strengthening OpenLoop’s Virtual Care Ecosystem OpenLoop, the Iowa-based telehealth infrastructure company known for…
ByIs the $2.5 Billion Insilico Medicine-Bora Pharmaceuticals Alliance the Blueprint for AI-Native Pharma’s Next…
Key Highlights A Landmark Alliance Bridging AI Discovery and Global Manufacturing In a move set to reshape the…
Can Sanofi’s Twin Lawsuits Against Pfizer and Moderna Reopen the Bill for $140 Billion-Plus…
Key Highlights Two Companies, One Shared Technology Dispute Sanofi’s complaints, filed as Translate Bio Inc v. Pfizer Inc…
Pfizer’s $10 Billion Innovent Alliance: Is China Now the Epicenter of Next-Gen Cancer Drug…
Key Highlights A Broad Multidrug Alliance Built for Scale The agreement spans up to 12 programs, eight originating…
Can J&J’s Newly FDA-Approved Dual-Energy Ablation Catheter Help It Reclaim Ground Lost to Boston…
Key Highlights A Strategic Answer to Lost PFA Ground Johnson & Johnson enters the U.S. dual-energy ablation market…
J&J’s $1 Billion Firefly Bio Buy: Has Big Pharma Finally Found a Way to…
Key Highlights A Novel Modality for a Notoriously Hard Target At the center of the acquisition is Firefly…
Can OpenLoop’s Acquisition of Hey Revia Redefine How AI Automates Telehealth Communication for Thousands…
Key Highlights A Landmark Acquisition Strengthening OpenLoop’s Virtual Care Ecosystem OpenLoop, the Iowa-based telehealth infrastructure company known for…
Is the $2.5 Billion Insilico Medicine-Bora Pharmaceuticals Alliance the Blueprint for AI-Native Pharma’s Next…
Key Highlights A Landmark Alliance Bridging AI Discovery and Global Manufacturing In a move set to reshape the…
Can Sanofi’s Twin Lawsuits Against Pfizer and Moderna Reopen the Bill for $140 Billion-Plus…
Key Highlights Two Companies, One Shared Technology Dispute Sanofi’s complaints, filed as Translate Bio Inc v. Pfizer Inc…
Pfizer’s $10 Billion Innovent Alliance: Is China Now the Epicenter of Next-Gen Cancer Drug…
Key Highlights A Broad Multidrug Alliance Built for Scale The agreement spans up to 12 programs, eight originating…
Can J&J’s Newly FDA-Approved Dual-Energy Ablation Catheter Help It Reclaim Ground Lost to Boston…
Key Highlights A Strategic Answer to Lost PFA Ground Johnson & Johnson enters the U.S. dual-energy ablation market…
J&J’s $1 Billion Firefly Bio Buy: Has Big Pharma Finally Found a Way to…
Key Highlights A Novel Modality for a Notoriously Hard Target At the center of the acquisition is Firefly…